3013-27-2 Usage
Uses
Used in Agrochemical Industry:
3-Fluoro-2-nitrotoluene is used as a key intermediate in the production of herbicides, fungicides, and insecticides. Its unique chemical structure contributes to the development of effective and targeted agrochemicals that protect crops from pests and diseases.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 3-Fluoro-2-nitrotoluene plays a crucial role as an intermediate in the synthesis of various medicinal compounds. Its presence in the molecular structure can influence the pharmacological properties and therapeutic effects of the resulting drugs.
Used in Dye and Pigment Manufacturing:
3-Fluoro-2-nitrotoluene is also utilized in the manufacturing of dyes and pigments, where its chemical properties contribute to the color intensity and stability of the final products.
Safety Precautions:
Due to its harmful nature, 3-Fluoro-2-nitrotoluene should be handled and stored with caution. It is considered hazardous if swallowed or inhaled and can cause skin and eye irritation. Proper safety measures, including the use of personal protective equipment and adherence to handling guidelines, are essential to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 3013-27-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,1 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3013-27:
(6*3)+(5*0)+(4*1)+(3*3)+(2*2)+(1*7)=42
42 % 10 = 2
So 3013-27-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H6FNO2/c1-5-3-2-4-6(8)7(5)9(10)11/h2-4H,1H3
3013-27-2Relevant academic research and scientific papers
NRF2 REGULATORS
-
Page/Page column 118, (2015/07/07)
The present invention relates to bis aryl analogs, pharmaceutical compositions containing them and their use as Nrf2 regulators.
Selective small molecules blocking HIV-1 tat and coactivator PCAF association
Zeng, Lei,Li, Jiaming,Muller, Michaela,Yan, Sherry,Mujtaba, Shiraz,Pan, Chongfeng,Wang, Zhiyong,Zhou, Ming-Ming
, p. 2376 - 2377 (2007/10/03)
Development of drug resistance from mutations in the targeted viral proteins leads to continuation of viral production by chronically infected cells, contributing to HIV-mediated immune dysfunction. Targeting a host cell protein essential for viral reproduction, rather than a viral protein, may minimize the viral drug resistance problem as observed with HIV protease inhibitors. We report here the development of a novel class of N1-aryl-propane-1,3-diamine compounds using a structure-based approach that selectively inhibit the activity of the bromodomain of the human transcriptional co-activator PCAF, of which association with the HIV trans-activator Tat is essential for transcription and replication of the integrated HIV provirus. Copyright
